Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/22/2025

Treatment of Streptococcal Infection and Influenza

Introduction to Treatment Guidelines

  • The American Thorax Society recommends treating both streptococcal infection and influenza simultaneously with oseltamivir and antibiotics, such as co-amoxiclav or doxycycline, to cover both conditions and potential bacterial superinfections 1, 2, 3

Antiviral Therapy for Influenza

  • The British Thorax Society suggests oseltamivir should be started if the patient presents within 48 hours of symptom onset with fever and acute influenza-like illness, or if the patient is hospitalized, severely ill, or immunocompromised, even if more than 48 hours from symptom onset 3, 4, 5
  • The dosing of oseltamivir is 75 mg orally every 12 hours for 5 days, with a reduction to 75 mg once daily if creatinine clearance is less than 30 mL/min 4, 5

Antibiotic Therapy for Streptococcal Infection

  • The American College of Physicians recommends co-amoxiclav as the preferred first-line agent for outpatient cases, covering Streptococcus pyogenes, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae, with doxycycline as an equally preferred alternative 1, 2, 3
  • For severe cases requiring hospitalization, the Infectious Diseases Society of America suggests IV combination therapy with co-amoxiclav or a 2nd/3rd generation cephalosporin plus a macrolide, with a duration of 10-14 days for severe pneumonia and up to 21 days if S. aureus or Gram-negative bacteria are confirmed or suspected 4, 6, 3

Critical Clinical Considerations

  • The European Respiratory Society states that antibiotics are essential in this scenario due to the high risk of severe secondary bacterial infections, particularly with Streptococcus pyogenes, which can rapidly progress to invasive disease, empyema, or sepsis 6, 7, 3
  • The American Thorax Society recommends using CURB-65 scoring for hospitalized patients to assess severity, with a score of 3 or more indicating severe pneumonia requiring aggressive IV combination therapy 1, 2, 5

Supportive Care

  • The American Academy of Pediatrics suggests antipyretics such as acetaminophen or ibuprofen for fever control, ensuring adequate hydration, and maintaining SpO2 above 92% with supplemental oxygen if needed 3, 5, 7